Recent Posts
- Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best – and First-in-Class Ophthalmic Medicines
- AndzonBio1 raises initial €3M in seed funding to advance breakthrough treatments for Cardiovascular, Renal and Metabolic Disorders
- Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis focused Pipeline
- ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)
- Inserm Transfert and AdBio Partners launch AndzonBio®